Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.
about
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cellsRequirements for activation and RAFT localization of the T-lymphocyte kinase Rlk/TxkBruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding proteinMolecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinaseTxk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon gamma production in human T lymphocytesDirect inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding proteinA congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humansStructural and functional studies of the intracellular tyrosine kinase MATK gene and its translated productBAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagementEtk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cellsIdentification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cgamma, Grb2, and Vav after B cell antigen receptor activationRegulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinaseBinding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinaseMissense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiencyGranulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinasesStructural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase diseaseBinding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interactionTec kinase associates with c-kit and is tyrosine phosphorylated and activated following stem cell factor bindingMutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemiaCD20 deficiency in humans results in impaired T cell-independent antibody responsesThe Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and diseaseSignal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2The molecular pathology of primary immunodeficienciesNeuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinaseChronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted AgentsSecond-generation inhibitors of Bruton tyrosine kinaseTargets for Ibrutinib Beyond B Cell MalignanciesTyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linkingHuman Emt tyrosine kinase is specifically expressed both in mature T-lymphocytes and T-cell associated hematopoietic malignanciesBruton's tyrosine kinase (Btk) associates with protein kinase C muAlternatively spliced isoforms of TFII-I. Complex formation, nuclear translocation, and differential gene regulationProtein-tyrosine phosphatase D1, a potential regulator and effector for Tec family kinasesPhosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cellsBiochemical interactions integrating Itk with the T cell receptor-initiated signaling cascadeMechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-IIdentification of phosphorylation sites for Bruton's tyrosine kinase within the transcriptional regulator BAP/TFII-IThe role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cellsThe adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytesProteolytic activation of ETK/Bmx tyrosine kinase by caspasesFunctional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx
P2860
Q21195261-E2FB7708-7111-40AC-AE83-DD8EFB8B3AB5Q21263140-7890DF99-E7B1-4CAB-8872-C752FE0FC9DCQ22009897-FD654333-C2E8-4E5C-B9C9-97FA08D82349Q22010641-A21AD316-6F02-44C6-96AB-2B010813068FQ22010666-9C029BCD-97B9-4C87-BD5B-3CC974506CD7Q24291740-2C7785A8-433A-4032-8868-BFC50BE603F9Q24301360-26942932-1123-418B-A2D6-9750F1FC14C7Q24306629-170A0573-441E-45AD-A35B-A25D0CBD15A8Q24316165-A2CB9665-C7C2-4881-9465-4A945828F22DQ24319902-17790FDE-B799-4610-AD47-1A241E9F663FQ24320077-21C9088F-5DA7-40B8-BFBE-0CC18FAF1489Q24554472-5F2EB10F-C1C3-4BC5-B405-DB8E55EB8629Q24562166-43ECEFF6-54E4-4448-975F-2FCD8147E717Q24562187-0A28FAFB-15DB-424F-B734-3EFC8DDE1C25Q24563242-E587C329-0E90-4278-8F00-0BA3842DC111Q24564000-AAE49FB9-282C-44D2-8614-9E8605F399B9Q24564184-55E3FF6E-5004-4BF2-8907-744EAAB6F150Q24607293-8F0F981F-8612-4044-8351-F03BFBAE78F4Q24652812-B3169C29-7D4D-4EAD-BD1B-D24C0D51B588Q24653638-0EB0A0E0-18A0-4197-93BA-C07A8C64F45BQ24677033-9A23C950-BF67-4E49-A3B8-45CDE2D745DEQ24680231-A723584A-F46C-46CD-8915-09EB954953EEQ24685932-A9E7898B-4BCF-4C3B-8B5D-B3C18C42E5E2Q24746249-4B72C829-0615-4962-A742-EF7869CA6A1DQ26764833-FFA4A3E7-1104-4353-A24A-57BD1887EBCBQ28076118-9F7EFAA3-91F7-4653-8A44-93CA7E7A35C9Q28087772-934CBB3A-4713-4E0A-AA01-B6A161F1B31CQ28118280-D7CEE402-27E8-4308-95F0-8B7E27BC0612Q28137838-235810BA-826E-412B-A41B-71DC654DCF70Q28137886-E56F6315-25F2-4462-B8F6-D8389E2B01FBQ28138348-84B2B8FB-1EF3-4391-8793-4C7009B2407EQ28140037-AEE87353-C182-4046-95C6-76C594819873Q28140934-EC7D9A3D-73E1-46A4-873A-6816BD3D997CQ28142714-6717E6DC-7CCF-4DA8-8D42-2AE21BAF0A54Q28185235-0F81068D-F6F7-4625-AE42-7F4B87474E58Q28190512-431283D0-859E-4647-9E84-549FA7112420Q28191639-3E386B97-CEEE-48BA-85CC-737B54657E33Q28207229-7EF924A1-8CC2-4C23-95A6-EBC9E696C3AFQ28208294-896EBF6A-356F-4615-8571-47DEAE89DF53Q28212744-AEA4038F-25A4-4203-879C-16CD015F56F8
P2860
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Deficient expression of a B ce ...... n X-linked agammaglobulinemia.
@ast
Deficient expression of a B ce ...... n X-linked agammaglobulinemia.
@en
type
label
Deficient expression of a B ce ...... n X-linked agammaglobulinemia.
@ast
Deficient expression of a B ce ...... n X-linked agammaglobulinemia.
@en
prefLabel
Deficient expression of a B ce ...... n X-linked agammaglobulinemia.
@ast
Deficient expression of a B ce ...... n X-linked agammaglobulinemia.
@en
P2093
P1433
P1476
Deficient expression of a B ce ...... n X-linked agammaglobulinemia.
@en
P2093
Kubagawa H
Mohandas T
Parolini O
Rawlings DJ
Saffran DC
Sparkes RS
P304
P356
10.1016/0092-8674(93)90667-F
P407
P577
1993-01-01T00:00:00Z